Related Experiment Video
Updated: Apr 26, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Novel TCAP mutation c.32C>A causing limb girdle muscular dystrophy 2G.
Amirtharaj Francis1, Balaraju Sunitha2, Kandavalli Vinodh1
1CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
This study identifies novel mutations in the TCAP gene causing Limb-Girdle Muscular Dystrophy type 2G (LGMD2G) in Indian families. These genetic findings explain the muscle disorder and highlight TCAP
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Telethonin (TCAP) is crucial for sarcomere structure, anchoring titin in the Z-disc.
- Mutations in TCAP cause Limb-Girdle Muscular Dystrophy type 2G (LGMD2G), a rare muscle disorder.
- LGMD2G is characterized by progressive muscle weakness, calf hypertrophy, and ambulation loss.
Purpose of the Study:
- To investigate the genetic basis of LGMD2G in Indian Dravidian families.
- To identify novel mutations in the TCAP gene associated with LGMD2G.
- To characterize the clinical presentation of LGMD2G in the studied cohort.
Main Methods:
- Recruitment of 300 individuals with autosomal recessive LGMD (ARLMD).
- Clinical examination and immunoblotting to assess muscle pathology and telethonin levels.
- Genetic analysis including sequencing to identify mutations in the TCAP gene.
Main Results:
- Identified 8 LGMD2G cases from 7 unrelated Dravidian families.
- Discovered two novel homozygous TCAP mutations: a nonsense mutation (c.32C>A, p.(Ser11*)) and a duplication (c.26_33dupAGGTGTCG, p.(Arg12fs31*)).
- Observed complete absence or severe reduction of telethonin in affected individuals.
Conclusions:
- TCAP gene mutations are a cause of LGMD2G in the Indian population.
- The identified mutations likely lead to truncated proteins or nonsense-mediated decay, causing muscle dysfunction.
- This is the first report linking TCAP mutations to LGMD2G in India.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Cardiomyopathy II: Dilated Cardiomyopathy
Huntington Disease l: Introduction